GlassScriptPhysician profile
Ethan Mcbrayer
NPI 1821652843
$4,812.16
in general payments reported to CMS, 2019-2025
34 companies · $1,725 in 2025
The $1,725 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.60 · 2021: $12.68 · 2022: $1,061 · 2023: $1,115 · 2024: $877 · 2025: $1,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,716.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $937.67 | 2022-2023 | Xeomin |
| Novo Nordisk INC | $449.34 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $448.16 | 2023-2025 | Repatha, Evenity, Otezla |
| Abbvie INC. | $388.27 | 2023-2025 | |
| Dexcom, INC. | $287.15 | 2022-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $255.74 | 2022-2025 | |
| Glaxosmithkline, LLC. | $237.98 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $233.96 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $220.81 | 2022-2025 | |
| Organogenesis INC. | $168.73 | 2023-2025 | Puraply Wound Matrix, Puraply |
| Astrazeneca Pharmaceuticals LP | $151.94 | 2022-2025 | Airsupra, Farxiga |
| Otsuka America Pharmaceutical, INC. | $138.83 | 2022-2025 | Rexulti |
| Corium, LLC | $102.31 | 2023-2025 | Azstarys |
| Astellas Pharma US INC | $102.05 | 2024-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.47 | 2023-2025 | Jardiance |
Show all 34 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Mcbrayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.